DR PRIYOMI STEVENSON

(MD) (FRANZCP)

Psychiatrist | Women’s Mental Health

& General Adult Psychiatry

For referring DERMATOLOGISTS

Specialist psychiatric care alongside isotretinoin treatment.

Isotretinoin can be transformative for people living with acne. For those with a history of mental illness, however, treatment may raise additional questions about psychiatric stability, potential mood changes and appropriate monitoring.


While the relationship between isotretinoin and psychiatric symptoms remains uncertain, updated guidance from the Therapeutic Goods Administration (2025) and the Australasian College of Dermatologists (2024) highlights the importance of mental health assessment, ongoing monitoring and collaborative care where clinically indicated.


Specialist psychiatric input can help patients and dermatologists navigate these complexities through individualised assessment, thoughtful risk formulation and coordinated care, supporting informed treatment decisions while maintaining access to effective acne treatment.

Refer a Patient

Download Referral Information

90-minute
comprehensive
assessments

  • Australia-wide
    telehealth

  • Face to Face

Sunshine Coast

(QLD)

Comprehensive
GP correspondence

Collaborative
shared care

At a glance

Patients

Adults

Consultation format

Australia-wide via telehealth or in-person on the Sunshine Coast (Queensland)

Initial assessment

90-minute comprehensive psychiatric assessment

ADHD assessments

Two-stage assessment pathway

Reports

Comprehensive correspondence following assessment

Referrals accepted from

GPs, specialists and nurse practitioners

Referral required for Medicare

Yes

Medicare item number required

No

WhEN TO CONSIDER REFERRAL

When psychiatric input may be helpful

When psychiatric input may be helpful

Specialist assessment may be considered for patients with:

  • Pre-existing psychiatric illness

  • A history of self-harm, suicidality or psychiatric hospitalisation

  • Diagnostic uncertainty or complex psychotropic treatment

  • Concerns about psychiatric stability before commencing isotretinoin

  • Emerging or persistent psychiatric symptoms during treatment

What makes this practice different

Comprehensive 90-minute assessments
Time to understand the whole picture rather than simply reviewing symptoms.

Whole-person formulation
Assessment considers biological, psychological and social factors alongside each woman’s individual goals and circumstances.

Evidence-based psychiatry
Treatment recommendations are informed by contemporary psychiatric evidence and tailored to the individual.

Collaborative Shared Care

Treatment recommendations are informed by contemporary psychiatric evidence and tailored to the individual.

Evidence-based psychiatry
Treatment recommendations are informed by contemporary psychiatric evidence and tailored to the individual.

Who I see

The practice provides specialist psychiatric assessment and ongoing management for patients aged 18 to 65 years throughout Australia via telehealth and in-person on the Sunshine Coast (Queensland).

Patients commonly seek assessment and treatment for:
• Isotretinoin-related psychiatric assessment and mental health monitoring

• ADHD
• Anxiety disorders
• Depression and mood disorders
• Trauma-related disorders
• Personality disorders
• Burnout and chronic stress
• Perimenopausal mental health
• Relationship and emotional difficulties
• Life transitions
• Diagnostic clarification
• Medication optimisation

If you’re unsure whether a referral is appropriate, you’re welcome to contact the practice before referring.

When telehealth may not be the most appropriate model of care

The practice provides planned outpatient psychiatric care via telehealth throughout Australia, alongside face-to-face consultations on the Sunshine Coast, Queensland.

Telehealth offers accessible, individualised psychiatric care for many patients. However, some presentations may be better supported by in-person assessment, multidisciplinary involvement or more intensive follow-up. Face-to-face consultations may allow greater flexibility depending on individual clinical circumstances.

Telehealth may not be appropriare for :


• Children and adolescents under 18 years

  • Perinatal psychiatric care during pregnancy and the first 12 months postpartum, including women requiring in person assessment or monitoring because of an elevated risk of postpartum psychosis

  • Active eating disorders requiring specialist or multidisciplinary management

  • Acute suicidal ideation, acute suicidality or immediate risk of self-harm

  • Patients requiring urgent or crisis psychiatric assessment

  • Bipolar affective disorder where there is current instability, acute relapse, intensive medication adjustment or a need for frequent clinical monitoring

  • Severe alcohol or substance use disorders, particularly where specialist addiction treatment is required

  • Presentations requiring frequent or intensive psychiatric review beyond the scope of planned outpatient telehealth care

  • Presentations where regular face-to-face assessment, physical examination, multidisciplinary care or hospital-based services are likely to provide a more appropriate model of care

  • WorkCover and CTP matters

  • Medico-legal assessments, independent medical examinations and medico-legal reports

    The practice welcomes referrals for patients with personality disorders where planned outpatient psychiatric care is clinically appropriate.


The referral journey

Referral received

Referral is sent securely via Medical Objects, Xestro or secure email.

→

↓

Referral reviewed

Every referral is personally reviewed to ensure the practice is the right fit.

→

↓

Appointment offered

If accepted, the patient will be contacted directly to arrange an appointment.

→

↓

Comprehensive assessment

Thoughtful assessment and formulation tailored to the woman’s needs.

→

↓

GP report

Comprehensive correspondence provided with patient consent.

→

↓

Ongoing shared care

Collaborative care with you to support the best outcomes for your patient.

Who should send the referral, gp OR DERMATOLOGIST?

Referrals & Medicare Rebates


Referrals are welcomed directly from treating dermatologists or GPs.


The applicable Medicare item depends on the nature of the assessment and whether ongoing psychiatric care is indicated:

  • One-off assessment and management plan: MBS item 291 (telehealth equivalent 92435) requires a referral from a GP or participating nurse practitioner.

  • Initial psychiatric assessment with ongoing specialist care: MBS item 296 (telehealth equivalent 92437) may be eligible for a Medicare rebate following a direct dermatologist referral, subject to MBS requirements.


Patients presenting with a dermatologist referral should be aware that a Medicare rebate cannot be guaranteed, as the appropriate billing pathway may only become clear following assessment.


For greater certainty regarding rebate eligibility and Medicare Safety Net benefits, patients are encouraged to obtain a GP referral before their appointment.

dermatologist Referral information

To assist with assessment, please include the following where known or readily available:

  • Reason for referral

  • Relevant medical history

  • Current medications

  • Previous psychiatric history

  • Recent ECG, if available in case psychotropic medication is warranted

  • Recent and relevant pathology, investigations or specialist correspondence

  • Patient's General Practitioner Specialist details (for copies of Correspondance)


An ECG or additional investigations are not required prior to referral. Any further assessments can be arranged if clinically indicated.

Referring dermatologist do not need to specify a Medicare item number. The appropriate item is selected following assessment in accordance with the Medicare Benefits Schedule.

How to refer

Referrals can be sent securely via:

Medical Objects
(Your practice details)

Xestro Secure Messaging
(Your practice details)

Secure Email
referrals@drpriyomi.com.au

What happens next?
Every referral is personally reviewed. If accepted, the patient will be contacted directly to arrange an appointment. Following assessment, a comprehensive report outlining the diagnostic formulation, recommendations and management plan will be forwarded to the referring clinician with the patient’s consent.

Scope of Care & Urgent Mental Health Concerns

This service provides individualised psychiatric assessment and recommendations for patients with existing mental health conditions or emerging psychiatric concerns before or during isotretinoin treatment. Assessment considers psychiatric stability, potential risks and appropriate monitoring, supporting collaborative care with the treating dermatologist and their GP.


The practice provides planned, non-urgent outpatient psychiatric care and does not offer crisis or emergency services. Patients experiencing acute psychiatric deterioration, immediate safety concerns or requiring urgent assessment should seek care through their local GP, mental health crisis team or nearest emergency department.


For further information, please refer to our Emergency & Crisis Support page.

Refer a Patient